|
|
This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2010) |
| Systematic (IUPAC) name | |
|---|---|
| 1-{10-[2-(dimethylamino)propyl]-10H-phenothiazin-2-yl}ethanone | |
| Clinical data | |
| Pregnancy cat. | Contraindicated Passes into breast milk |
| Legal status | ℞ Prescription only |
| Routes | Oral |
| Pharmacokinetic data | |
| Metabolism | Hepatic |
| Excretion | Renal and fecal |
| Identifiers | |
| CAS number | 13461-01-3 |
| ATC code | None |
| PubChem | CID 26035 |
| DrugBank | DB01615 |
| ChemSpider | 24249 |
| UNII | 984N9YTM4Y |
| ChEBI | CHEBI:53770 |
| Chemical data | |
| Formula | C19H22N2OS |
| Mol. mass | 326.456 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Aceprometazine (INN) is a phenothiazine derivative prescription drug with neuroleptic and anti-histamine properties. It is not widely prescribed. It may be used in combination with meprobamate for the treatment of sleep disorders. This combination is available in France under the trade name Mepronizine.
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)